Clinical Data

Selected news for the healthcare topic - Clinical Data, collected since 10/2017. This healthcare topic shares news with COVID-19, Oncology, Food and Drug Administration, Biotech, Clinical Research and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/7/2021 Todos and NLC Pharma report positive clinical data for Covid-19 test medicaldevice-network.com Todos and NLC Pharma report positive clinical data for Covid-19 test] Todos and NLC Pharma report positive clinical data for Covid-19 test A steady inverse link between ct value and 3CL protease activity was found in hospitalised and non-hospitalised Covid-19 subjects. Todos Medical and its joint venture partner NLC Pharma have reported positive clinical validation data from a study where the former’s SARS-CoV-2 ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill wxerfm.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 US FDA grants 510(k) clearance for BD Rotarex System expanded indications medicaldevice-network.com Todos and NLC Pharma report positive clinical data for Covid-19 test] US FDA grants 510(k) clearance for BD Rotarex System expanded indications The Rotarex Atherectomy System now has expanded indications for treatment inside peripheral arteries. The US Food and Drug Administration (FDA) has granted 510(k) clearance for Becton, Dickinson and Company’s (BD) Rotarex Atherectomy System expanded indications. A rotational excisional device, the Rotarex Atherectomy System is ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill dukefmduluth.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 COVID-19 vaccine linked to reduction in US senior deaths, HHS says fox26houston.com WASHINGTON - With more than 83% of U.S. adults aged 65 and older vaccinated against the novel coronavirus, a new study suggests vaccines have reduced COVID-19 infections and deaths in seniors.According to the study published by the Department of Health and Human Services, the purpose of the research was to identify associations between COVID-19 infections, hospitalizations and deaths among Medicare fee-for-service (FFS) beneficiaries and the proportion ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill hot96.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill q106fm.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown.The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 COVID-19 vaccine linked to reduction in US senior deaths, HHS says fox6now.com WASHINGTON - With more than 83% of U.S. adults aged 65 and older vaccinated against the novel coronavirus, a new study suggests vaccines have reduced COVID-19 infections and deaths in seniors.According to the study published by the Department of Health and Human Services, the purpose of the research was to identify associations between COVID-19 infections, hospitalizations and deaths among Medicare fee-for-service (FFS) beneficiaries and the proportion ...
10/7/2021 Merck's molnupiravir will be a blockbuster drug during pandemic. What about endemic COVID-19? | FiercePharma FiercePharma ... Ronny Gal estimates.Gal used the influenza market as the benchmark for his calculation and incorporated efficacy data from molnupiravir and COVID-19 vaccines. He now projects Merck—as the only company with positive clinical data —will take half of the endemic oral drug market, with Pfizer and Roche potentially sharing the rest if their contenders prove successful.Molnupiravir’s 50% reduction in hospitalization and death risk came from the ...
10/7/2021 Denali makes ALS play, hustling Sanofi-partnered drug into phase 2 and sharing early data on internal program FierceBiotech ... of DNL343, it will also start the process of answering outstanding questions about how patients respond to the molecule.“Primary pushback from investors is: hard to know what we have until there is more clinical data , biology around ALS is extremely challenging, preclinical models are not well predictive,” analysts at Jefferies wrote in a note to investors. The analysts expect Denali to eventually land a big partnership to fund ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill froggyweb.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill kelofm.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill krro.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 Zacks Investment Research Downgrades Matinas BioPharma (NYSEAMERICAN:MTNB) to Hold - Transcript Daily transcriptdaily.com ... Äôs lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia. ‚ÄúGet Matinas BioPharma alerts: Separately, HC ...
10/7/2021 Zacks Investment Research Downgrades Matinas BioPharma (NYSEAMERICAN:MTNB) to Hold - Stock Observer thestockobserver.com ... Äôs lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia. ‚ÄúGet Matinas BioPharma alerts: Separately, HC ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill - The Jerusalem Post jpost.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore, and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill Yahoo News ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown.The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill my957.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill wimz.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...
10/7/2021 Malaysia buys 150,000 courses of Merck's COVID-19 pill whtc.com ... would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in ...